Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for Q4074. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
16
Median % of Medicare
--
Rate range
$77.04 - $160.11
Q4074 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Arizona | $149.92 | -- | -- | 2026 |
| District of Columbia | $158.92 | -- | Not required | 2026 |
| Idaho | $137.30 | -- | Not required | 2026 |
| Indiana | $157.42 | -- | Required | 2025 |
| Maine | $158.92 | -- | -- | 2026 |
| Minnesota | $77.04 | -- | -- | 2026 |
| Nebraska | $160.11 | -- | -- | 2026 |
| New Mexico | $148.24 | -- | -- | 2025 |
| Oklahoma | $158.92 | -- | -- | 2026 |
| South Carolina | $147.53 | -- | -- | 2026 |
| Texas | $158.92* | -- | -- | 2026 |
| Utah | $158.92* | -- | Not required | 2025 |
| Virginia | $158.91 | -- | -- | 2025 |
| Vermont | $150.97 | -- | -- | 2026 |
| Wisconsin | $158.92 | -- | -- | 2025 |
| Wyoming | $139.22 | -- | -- | 2022 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related state-specific services codes
- C1716 - Brachytherapy source, non-stranded, gold-198, per source
- C1717 - Brachytherapy source, non-stranded, high dose rate iridium-192, per source
- C1719 - Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source
- C2616 - Brachytherapy source, non-stranded, yttrium-90, per source
- C2634 - Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source
- C2635 - Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source
- C2636 - Brachytherapy linear source, non-stranded, palladium-103, per 1 mm
- C2638 - Brachytherapy source, stranded, iodine-125, per source
All 325 codes from Q4001 to Q4420 or every state-specific services code by number.
Frequently asked questions
How much does Medicaid pay for Q4074?
16 state Medicaid programs publish a fee-for-service rate for Q4074 (iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms), ranging from $77.04 in Minnesota to $160.11 in Nebraska. The full table on this page lists every publishing state's current rate.
Which state pays the most for Q4074?
Nebraska publishes the highest Medicaid rate for Q4074 at $160.11. Minnesota publishes the lowest at $77.04.
Does Q4074 require prior authorization under Medicaid?
1 of the 16 publishing states flag Q4074 as requiring prior authorization (always or conditionally) on their fee schedules. States without a flag publish no PA indicator for this code - that means "not published", not "no PA required".